Characterization of BRCA1 ring finger variants of uncertain significance

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2010-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-009-0438-6PMID 19543972PMCID PMC4283813
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history

  2009cited by this paper
• UvA-DARE ( Digital Academic Repository ) A method to assess the clinical significance of unclassified variants in the BRCA 1 and BRCA 2 genes based on cancer family history

  2009cited by this paper
• A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer–Predisposition Genes

  2008influential reference
• Assessment of functional effects of unclassified genetic variants

  2008cited by this paper
• Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators.

  2008cited by this paper
• Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.

  2008cited by this paper
• Classification of missense variants of unknown significance in BRCA1 based on clinical and tumor information

  2007cited by this paper
• Limited family structure and BRCA gene mutation status in single cases of breast cancer.

  2007cited by this paper
• A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.

  2007cited by this paper
• Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance.

  2006cited by this paper
• Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility.

  2006cited by this paper
• Histopathology of BRCA1- and BRCA2-associated breast cancer.

  2006cited by this paper
• Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral

  2005cited by this paper
• BRCA1 RING Domain Cancer-predisposing Mutations

  2001cited by this paper
• The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*

  2001influential reference
• Novel germline BRCA1 and BRCA2 mutations in breast and breast/ovarian cancer families from the Czech Republic

  2001cited by this paper
• Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity

  2001cited by this paper
• BRCA1: exploring the links to transcription.

  2000cited by this paper
• Mapping the Functional Domains of BRCA1

  1999cited by this paper
• High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families

  1998cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Unusual case of Smith-Lemli-Opitz syndrome "type II".

  1995cited by this paper

• Comprehensive evaluation and efficient classification of BRCA1 RING domain missense substitutions.

  2022cites this paper
• Computational structural assessment of BReast CAncer type 1 susceptibility protein (BRCA1) and BRCA1-Associated Ring Domain protein 1 (BARD1) mutations on the protein-protein interface.

  2022cites this paper
• Application of ACMG criteria to classify variants in the human gene mutation database

  2019cites this paper
• GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes

  2019influential citation
• Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants.

  2019cites this paper
• A new bioinformatics tool to help assess the significance of BRCA1 variants

  2018cites this paper
• A Multiplex Homology-Directed DNA Repair Assay Reveals the Impact of More Than 1,000 BRCA1 Missense Substitution Variants on Protein Function.

  2018cites this paper
• A multiplexed homology-directed DNA repair assay reveals the impact of ~1,700 BRCA1 variants on protein function

  2018cites this paper
• Unusual recurrence of breast cancer in a BRCA‐variant patient after fat grafting

  2018cites this paper
• BRCA1/2 germline missense mutations: a systematic review

  2017cites this paper
• Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory.

  2017cites this paper
• Resolving the Functional Significance of BRCA1 RING Domain Missense Substitutions

  2016cites this paper
• Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity

  2016cites this paper
• Functional Assessment of Genetic Variants with Outcomes Adapted to Clinical Decision-Making

  2016cites this paper
• Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers

  2015cites this paper
• Massively Parallel Functional Analysis of BRCA1 RING Domain Variants

  2015cites this paper
• Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

  2014cites this paper
• Multifactorial Likelihood Assessment of BRCA1 and BRCA2 Missense Variants Confirms That BRCA1:c.122A>G(p.His41Arg) Is a Pathogenic Mutation

  2014cites this paper
• BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.

  2013cites this paper
• Analysis of BRCA1 Variants in Double‐Strand Break Repair by Homologous Recombination and Single‐Strand Annealing

  2013cites this paper
• Assessing Genetic Variants of Uncertain Significance: The Example of Breast Cancer

  2013cites this paper
• BRCA 1 R 1699 Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk

  2012cites this paper
• BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk

  2012cites this paper
• Classification of missense substitutions in the BRCA genes: A database dedicated to Ex‐UVs

  2012cites this paper
• A review of a multifactorial probability‐based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)

  2012cites this paper
• Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination.

  2010cites this paper
• The Clinical Significance of Unknown Sequence Variants in BRCA Genes

  2010cites this paper
• BRCA 1 / 2 SequenceVariantsofUncertainSignificance : APrimer for Providers toAssist inDiscussionsand inMedicalManagement

  year unknowncites this paper